Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Copy number variations in urine cell free DNA as biomarkers in advanced prostate cancer

26 Apr 2016

Abstract excerpt

// Yun Xia 1,2 , Chiang-Ching Huang 3 , Rachel Dittmar 2 , Meijun Du 2 , Yuan Wang 2 , Hongyan Liu 2 , Niraj Shenoy 4 , Liang Wang 2 and Manish Kohli 4 1 Department of General Surgery, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China 2 Department of Pathology and MCW Cancer Center, Medical College of Wisconsin, Milwaukee, WI, USA 3 Joseph J. Zilber School of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Prostate Cancer Treatment and Research
Share to Renal cell carcinoma treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27127882
DOI: 10.18632/oncotarget.9027

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Copy number variations in urine cell free DNA as biomarkers in advanced prostate cancerPMID 27127882Read ↗

Plasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancerSemantic proximity Read ↗

Integrative genomic and epigenomic profiling in plasma and urinary cell-free DNA improves early risk stratification of newly diagnosed prostate cancerSemantic proximity Read ↗

Chromosomal Instability in Cell-Free DNA Is a Serum Biomarker for Prostate CancerSemantic proximity Read ↗

Cell-Free DNA Detection of Tumor Mutations in Heterogeneous, Localized Prostate Cancer Via Targeted, Multiregion Sequencing.Semantic proximity Read ↗

Comparison of androgen receptor mutation detection between plasma extracellular vesicle DNA and cell-free DNA and its relationship to prostate cancer prognosis.Semantic proximity Read ↗

A sensitive and specific non-invasive urine biomarker panel for prostate cancer detectionSemantic proximity Read ↗

Clinical determinants for successful circulating tumor DNA analysis in prostate cancerSemantic proximity Read ↗

Genomic Profiling of Prostate Cancer: An Updated ReviewSemantic proximity Read ↗

Liquid biopsy in prostate cancer: A novel dual biomarker analysis approach integrating circulating tumor cells and circulating tumor DNA data.Semantic proximity Read ↗

Genetic profiling of hormone-sensitive and castration-resistant prostate cancers and identification of genetic mutations prone to castration-resistant prostate cancer.Semantic proximity Read ↗

Future directions for precision oncology in prostate cancerSemantic proximity Read ↗

Clinical and pathological features associated with circulating tumor DNA content in real-world patients with metastatic prostate cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.